Hoag clinical cardiac electrophysiologist Dr. Rajesh Banker holds the dual chamber leadless pacemaker, which is smaller than an AAA battery. Two of Orange County’s biggest hospitals, Hoag Memorial ...

Wireless or leadless pacemakers, commonly implanted in adults, may be a safe and effective short-term option for children with slow heartbeats, according to new research published today in Circulation ...

A new leadless dual-chamber pacemaker for patients with heart issues could be available later this year, according to new research published last week and funded by Abbott Medical. The U.S. Food and ...

Cardiologists have marked a medical first in South Africa with the successful implantation of a tiny leadless pacemaker.

The human heart rate is under the influence of various hormonal and neural control mechanisms. Normally, conduction of an electrical impulse through the heart begins at the sinoatrial (SA) node and ...

Patients who received leadless pacemakers experienced fewer short-term and mid-term complications overall than those who had traditional transvenous pacemakers, a Cleveland Clinic-led research study ...

BATON ROUGE, La.- Dr. Robert Drennan, electrophysiologist at CIS, used the leadless pacemaker by Abbott Aveir™ on July 15, at Baton Rouge General Medical in the catheterization laboratory. Dr. Drennan ...

This summer, doctors at UnityPoint Health performed the QCA's first leadless pacemaker procedure. Now, Dr. Helbert Acosta breaks down the significance.

Just a few weeks after Abbott presented the successful results of a trial of its Aveir DR dual-chamber leadless pacemaker system—data that it said had been promptly submitted for regulatory review—the ...

A prototype for a leadless pacemaker that converts the heart's oscillations into voltage generated 10.9% of the energy needed to stimulate one heartbeat in a laboratory benchtop experiment. If the ...

Leadless pacemaker technology represents a significant advancement in cardiac rhythm management, eliminating the need for transvenous leads and reducing many of the complications associated with ...

ABBOTT PARK, Ill., Nov. 12, 2021 /PRNewswire/ -- Abbott (NYSE: ABT) today announced new, late-breaking data from the global Leadless II IDE study evaluating Abbott's investigational Aveir leadless ...